Skip to main content
EMVISION MEDICAL DEVICES LTD logo

EMVISION MEDICAL DEVICES LTD — Investor Relations & Filings

Ticker · EMV ISIN · AU0000028375 ASX Manufacturing
Open in API
Filings indexed 304 across all filing types
Latest filing 2019-07-07 Capital/Financing Update
Country AU Australia
Listing ASX EMV

About EMVISION MEDICAL DEVICES LTD

https://emvision.com.au/

EMVision Medical Devices Ltd is a medical technology company focused on the development and commercialization of portable medical imaging devices. The company specializes in electromagnetic microwave imaging technology designed for the rapid diagnosis and monitoring of stroke and traumatic brain injury. Its primary product is a portable brain scanner intended for use at the point of care, including intensive care units, emergency departments, and ambulances. By utilizing non-ionizing radiation, the technology provides a safe, cost-effective, and mobile alternative to traditional neuroimaging modalities like CT and MRI. The device aims to facilitate earlier clinical intervention by enabling bedside assessment, potentially improving patient outcomes through faster detection of ischemic and hemorrhagic strokes.

Recent filings

Filing Released Lang Actions
Release of Restricted Securities from Escrow 1 page
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from EMvision Medical Devices Ltd regarding the release of restricted securities from escrow following the company's official quotation on the ASX. It details the number and class of securities, restriction periods, and compliance with ASX Listing Rule 3.10A. There is no financial data, earnings information, or detailed report content. The document is an update on capital structure and securities restrictions, fitting the category of Capital/Financing Update rather than a full financial report or regulatory filing. The document length is short and focused on a specific capital-related event.
2019-07-07 English
Appendix 3B 13 pages 301.9KB
Capital/Financing Update Classification · 100% confidence The document is titled 'Appendix 3B New issue announcement' and contains detailed information about the issuance of new securities, including the class of securities, number issued, exercise price, expiry date, and compliance with ASX rules. It includes sections on the calculation of placement capacity under ASX rules 7.1 and 7.1A, warranties to ASX, and other procedural details related to the issuance and quotation of additional securities. The document is a formal announcement of a new issue of securities and application for quotation on the ASX, consistent with regulatory requirements for capital raising disclosures. It does not contain financial statements, management discussion, or audit information, nor is it a report or presentation. Therefore, it fits the category of a Capital/Financing Update, which covers updates on company fundraising and capital structure changes.
2019-07-04 English
EMvision Appoints Head of Quality & Regulatory Affairs 2 pages 165.4KB
Board/Management Information Classification · 95% confidence The document is a company announcement about the appointment of a new Head of Quality and Regulatory Affairs. It focuses on personnel changes and organizational capability enhancement. There is no financial data, no report or presentation attached or referenced, and no mention of shareholder votes, dividends, or regulatory filings. The content clearly relates to management or board-level changes, specifically the appointment of a senior executive. Therefore, the document fits best under the category of Board/Management Information (MANG). The document length is short (3430 characters), consistent with a typical management announcement rather than a full report or detailed filing.
2019-07-02 English
Brain Scanner Development Update 4 pages 399.5KB
Investor Presentation Classification · 95% confidence The document is a detailed update on the development progress of a medical device by EMvision Medical Devices Ltd. It includes technical details about hardware and software improvements, clinical trial preparations, and future milestones. There is no indication that this is a financial report, earnings release, or regulatory filing. It is a product development update aimed at investors and the public, focusing on progress and future plans rather than financial results or governance matters. The document is not a report publication announcement since it contains substantive content rather than just announcing a report release. It is also not a call transcript or AGM material. The best fit is an Investor Presentation (IP) because it provides detailed information on product development, strategy, and clinical progress to inform investors and stakeholders.
2019-06-30 English
EMvision Appoints Clinical Advisory Board 4 pages 389.4KB
Board/Management Information Classification · 95% confidence The document is a press release announcing the appointment of a Clinical Advisory Board for EMvision Medical Devices Ltd. It details the members of the advisory board, their backgrounds, and the strategic role they will play in the company's development. There is no financial data, regulatory filing references, or report attachments. The content focuses on management and board-level appointments and organizational updates rather than financial results, regulatory compliance, or shareholder voting. Therefore, the document fits best under Board/Management Information (MANG), which covers announcements of changes in the company's board or senior management.
2019-06-11 English
Change of Director's Interest Notice 3 pages 184.1KB
Director's Dealing Classification · 100% confidence The document is titled 'Appendix 3Y Change of Director’s Interest Notice' and references ASX listing rule 3.19A.2 and section 205G of the Corporations Act. It details changes in the director's relevant interests in securities, including the number of shares held before and after the change, dates of transactions, and nature of the changes. This is a formal notification of personal share transactions by a company director. The document length is 4318 characters, which is consistent with a detailed director's dealing notice. There is no indication that this is a full financial report, audit, or other type of filing. Therefore, the document fits the definition of Director's Dealing (DIRS).
2019-06-04 English

Browse filings by year

8 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.